ANGELINI, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 39.990
AS - Asia 17.369
EU - Europa 11.467
AF - Africa 5.899
SA - Sud America 4.645
OC - Oceania 577
Continente sconosciuto - Info sul continente non disponibili 303
Totale 80.250
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.016
SG - Singapore 5.505
HK - Hong Kong 3.224
BR - Brasile 2.766
CN - Cina 1.983
VN - Vietnam 1.175
IT - Italia 1.071
FI - Finlandia 946
SE - Svezia 829
FR - Francia 788
DE - Germania 733
RU - Federazione Russa 607
PL - Polonia 596
UA - Ucraina 576
GB - Regno Unito 474
IE - Irlanda 347
AR - Argentina 309
TR - Turchia 266
NL - Olanda 257
AT - Austria 254
IN - India 248
MX - Messico 218
IQ - Iraq 216
AO - Angola 210
EC - Ecuador 207
PE - Perù 200
ZA - Sudafrica 198
PY - Paraguay 194
ID - Indonesia 192
BE - Belgio 188
SA - Arabia Saudita 186
CO - Colombia 185
ES - Italia 184
AL - Albania 182
TN - Tunisia 181
MA - Marocco 178
JO - Giordania 177
KE - Kenya 177
GR - Grecia 175
LB - Libano 172
AZ - Azerbaigian 169
LC - Santa Lucia 169
HN - Honduras 168
SI - Slovenia 168
CH - Svizzera 167
DO - Repubblica Dominicana 167
DZ - Algeria 167
PA - Panama 167
BZ - Belize 166
HU - Ungheria 166
BJ - Benin 165
KG - Kirghizistan 165
RS - Serbia 165
UZ - Uzbekistan 165
CW - ???statistics.table.value.countryCode.CW??? 164
AM - Armenia 163
LA - Repubblica Popolare Democratica del Laos 163
LV - Lettonia 163
KR - Corea 162
UY - Uruguay 162
VE - Venezuela 162
MU - Mauritius 161
GF - Guiana Francese 159
JM - Giamaica 158
KZ - Kazakistan 158
AE - Emirati Arabi Uniti 157
CV - Capo Verde 157
ME - Montenegro 157
YT - Mayotte 157
GH - Ghana 156
GM - Gambi 156
MY - Malesia 156
EG - Egitto 155
GT - Guatemala 155
NP - Nepal 155
TJ - Tagikistan 155
CZ - Repubblica Ceca 154
IL - Israele 154
JP - Giappone 154
ML - Mali 154
PR - Porto Rico 154
PT - Portogallo 154
CL - Cile 153
PH - Filippine 152
TZ - Tanzania 152
CY - Cipro 151
SK - Slovacchia (Repubblica Slovacca) 151
BW - Botswana 150
IS - Islanda 150
MK - Macedonia 150
UG - Uganda 150
GN - Guinea 149
PS - Palestinian Territory 149
TW - Taiwan 149
HR - Croazia 148
BO - Bolivia 147
KH - Cambogia 147
MG - Madagascar 147
MN - Mongolia 146
MW - Malawi 146
Totale 73.026
Salva come PNG Salva come JPEG
Città #
Fairfield 5.532
Woodbridge 3.250
Singapore 3.124
Hong Kong 3.089
Houston 2.735
Ashburn 2.730
Chandler 2.237
Seattle 2.022
Ann Arbor 1.954
Wilmington 1.868
Cambridge 1.822
Jacksonville 1.816
Princeton 1.054
Boardman 1.051
San Diego 854
Medford 740
Roxbury 616
Santa Clara 544
Helsinki 461
Beijing 458
Des Moines 449
Bytom 397
Dong Ket 342
Ho Chi Minh City 312
Guangzhou 289
Nanjing 220
Dublin 196
Los Angeles 195
Chicago 190
São Paulo 185
New York 175
Luanda 172
Amman 171
Hanoi 169
Menlo Park 166
Castries 165
Vienna 163
Baku 160
Tashkent 155
Cotonou 153
Padova 153
Panama City 151
Bamako 149
Vientiane 148
Conakry 145
Dushanbe 145
Nairobi 144
Kampala 142
Antananarivo 141
Ulan Bator 141
Bishkek 140
Phnom Penh 136
Podgorica 136
Lusaka 134
Praia 134
Nouakchott 133
Yerevan 133
Bridgetown 132
Riga 131
Managua 128
Montevideo 128
Munich 128
Lima 127
Willemstad 127
Abidjan 126
Accra 126
Libreville 126
Kigali 124
Nassau 121
Noumea 118
Harare 117
Dar es Salaam 116
San José 116
Kingstown 115
Dakar 114
Shanghai 113
Tallinn 113
Reykjavik 112
Havana 110
Kingston 110
Cayenne 106
Gaborone 103
Tbilisi 103
Addis Ababa 102
Andorra la Vella 102
Djibouti 100
Lilongwe 100
Ogden 100
Ouagadougou 100
Kinshasa 97
Ljubljana 97
Niamey 96
Rio de Janeiro 94
Banjul 93
Guatemala City 93
Tirana 93
London 92
Mamoudzou 92
Milan 92
Chisinau 91
Totale 49.510
Salva come PNG Salva come JPEG
Nome #
Regulation of Endoplasmic Reticulum-Mitochondria contacts by Parkin via Mfn2 286
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 266
Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population 237
A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function. 235
Acute quadriplegic myopathy in a 17 month old boy 216
Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy 210
Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants. 210
Parkinson-like features in ALS with predominant upper motor neuron involvement 207
Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease 204
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. 203
Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure. 200
Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2 200
Functional changes in Becker muscular dystrophy: Implications for clinical trials in dystrophinopathies 199
Heart involvement in muscular dystrophies due to sarcoglycan gene mutations 196
Hereditary spastic paraplegia associated with peripheral neuropathy: a distinct clinical and genetic entity 195
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 193
Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies 192
Progress in enzyme replacement therapy in glycogen storage disease type II 188
TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. 186
LGMD2E patients risk developing dilated cardiomyopathy 185
ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion 185
Cardioembolic stroke in Danon disease. 183
Autophagy dysregulation in Danon disease 182
Carnitine and acyltransferase in experimental neurogenic atrophies: changes with treatment 182
Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function 182
The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia 179
Study of Muscle Autophagy and Atrophy Markers in Different Phenotypes of Pompe Disease 178
A study on duplications of the dystrophin gene: Evidence of a geographical difference in the distribution of breakpoints by intron 177
Clinical phenotype, muscle MRI and muscle pathology of LGMD1F 177
Esophageal motor function in patients with myotonic dystrophy 175
Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample 175
Metabolic myopathies: the challenge of new treatments 175
Dominant optic atrophy caused by a novel OPA1 mutation: Disruption of the mitochondrial network with preserved bioenergetics. 174
Hypertrophic cardiomyopathy with mitochondrial myopathy. A new phenotype of complex II defect. 174
A mobile app for patients with Pompe disease and its possible clinical applications 173
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations 173
Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients 171
Radiological evidence of subclinical dysphagia in motor neuron disease 171
Familial ALS: clinical, genetic and morphological features. 171
Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I 170
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases 169
Abnormal free radical homeostasis and oxphos activity in ALS muscle 169
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? 169
Decreased expression of DMPK: correlation with CTG repeat expansion and fibre type composition in myotonic dystrophy type 1 169
Phenotype modulators in myophosphorylase deficiency 168
Optimization of respiratory chain enzymatic assays in muscle for the diagnosis of mitochondrial disorders. 168
A study on duplications of the dystrophin gene: evidence of a geographical difference in the distribution of breakpoints by intron. 168
Heart transplantation in patients with Inherited myopathies associated with end-stage cardiomyopathy: molecular and biochemical defects on cardiac and skeletal muscle 167
New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy 167
PREVALENCE OF UNSUSPECTED MYOPATHY IN INFANTS PRESENTING FOR CLUBFOOT SURGERY 166
Clinical and molecular characterization of limb girdle muscular dystrophy due to LAMA2 mutations. 166
Multisystem primary defect of LAMP-2 in Danon disease 166
Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes 166
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy 165
Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2) 165
Motor neuron disease in the Padua district of Italy: an epidemiological study 164
Cardiac involvement in Becker muscular dystrophy 164
MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. 163
MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy 163
Genetic epidemiology of myotonic dystrophy. 163
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease 162
Epidemiology of myotonic dystrophy in Italy: re-apprisal after genetic diagnosis 161
The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis 161
Unilateral calf hypertrophy due to S1-radiculopathy 159
A pilot trial with clenbuterol in amyotrophic lateral sclerosis 159
Gene expression profiling in dysferlinopathies using a dedicated muscle microarray 159
TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy 159
Right hemisphere dysfunction and emotional processing in ALS: an fMRI study 159
Reliability of the North Star Ambulatory Assessment in a multicentric setting 157
Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependency 157
Investigating the mechanism of chromosomal deletion: Characterization of 39 deletion breakpoints in introns 47 and 48 of the human dystrophin gene 157
Therapeutic advances in the management of Pompe disease and other metabolic myopathies 155
Clinical and pathological findings in families with X-linked spinal and bulbar muscular atrophy (Kennedy's disease). 155
Clinical and genetic characterization of an Italian family with slow-channel syndrome 155
“I have got something positive out of this situation”: psychological benefits of caregiving in relatives of young people with muscular dystrophy 154
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: Experience of the FSHD Italian National Registry 154
MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy 154
Deflazacort in Duchenne dystrophy: study of long term effect 153
Psychopathological features and suicidal ideation in amyotrophic lateral sclerosis patients. 153
Enzyme Replacement Therapy for Pompe Disease 153
Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells. 153
Exploring mental status in Friedreich's ataxia: a combined neuropsychological, behavioral and neuroimaging study. 151
Myoclonus in mitochondrial disorders. 151
Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. 151
Skeletal muscle sarcoplasmic reticulum phenotype in myotonic dystrophy 150
Tubular aggregates: Sarcoplasmic reticulum origin, calcium storage ability, and functional implications 150
Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1 148
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 148
Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facio-scapulo human muscular dystrophy. A potential target for pharmacological treatment? 148
Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? 147
Sphingomonas paucimobilis associated with localised calf myositis 147
X-inactivation patterns in female Leber's hereditary optic neuropathy patients do not support a strong X-linked determinant. 146
Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. 146
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD). 145
MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy 145
Prevalence of dystrophin-positive fibers in 85 duchenne muscular dystrophy patients 144
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation. 144
[An] enumeration shall be made.. 144
P. 5.7 Limb-girdle muscular dystrophy type 2E: Clinical, genetic and histopathological features of 27 European patients 143
Telethon Network of Genetic Biobanks: a key service for diagnosis and research on rare diseases. 143
Totale 17.140
Salva come PNG Salva come JPEG
Categoria #
all - tutte 255.938
article - articoli 220.977
book - libri 194
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.807
Totale 480.916
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.081 0 0 0 0 474 543 92 820 1.253 526 822 551
2021/202211.247 250 1.085 1.014 2.066 495 495 350 1.302 350 179 1.153 2.508
2022/20235.205 1.630 479 67 547 719 632 14 320 524 28 201 44
2023/20242.725 82 290 207 152 131 187 129 120 243 309 418 457
2024/202513.783 28 1.054 762 472 1.628 242 495 1.121 1.702 648 2.227 3.404
2025/202627.772 1.282 5.198 9.832 11.157 303 0 0 0 0 0 0 0
Totale 81.280